methylprednisolone has been researched along with Fat Necrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finazzo, F; Manzoni, P; Militello, MA; Re, MP; Vitaliti, G; Vitaliti, SM | 1 |
| Pai, KS; Park, MS; Yu, JE | 1 |
2 other study(ies) available for methylprednisolone and Fat Necrosis
| Article | Year |
|---|---|
Use of Zoledronic Acid in a Neonate with Subcutaneous Fat Necrosis Complicated with Severe, Refractory Hypercalcemia.
Topics: Bone Density Conservation Agents; Calcium; Drug Resistance; Fat Necrosis; Female; Furosemide; Glucocorticoids; Humans; Hypercalcemia; Infant, Newborn; Methylprednisolone; Sodium Potassium Chloride Symporter Inhibitors; Subcutaneous Fat; Term Birth; Zoledronic Acid | 2019 |
Congenital cavernous hemangioma exhibiting subcutaneous fat necrosis.
Topics: Fat Necrosis; Female; Glucocorticoids; Hemangioma, Cavernous; Hemostasis, Surgical; Humans; Infant, Newborn; Methylprednisolone | 2008 |